Pharmacogenomics Technology Market

Pharmacogenomics Technology Market aims to provide a comprehensive presentation of the global market for Pharmacogenomics Technology (Theranostics & CDx), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacogenomics Technology (Theranostics & CDx). Pharmacogenomics Technology Market contains market size and forecasts of Pharmacogenomics Technology (Theranostics & CDx) in global, including the following market information:
Global Pharmacogenomics Technology (Theranostics & CDx) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pharmacogenomics Technology (Theranostics & CDx) market was valued at US$ 9869.6 million in 2022 and is projected to reach US$ 24800 million by 2029, at a CAGR of 14.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Pharmacogenomics Technology (Theranostics & CDx) manufacturers include Illumina, Roche and Agilent etc. The top 3 company holds a share of more than 50%. North America takes up the largest sales market, with a share of more than 40%, followed by Europe and China, with the share of about 30% and 10% respectively.
We surveyed the Pharmacogenomics Technology (Theranostics & CDx) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmacogenomics Technology (Theranostics & CDx) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pharmacogenomics Technology (Theranostics & CDx) Market Segment Percentages, by Type, 2022 (%)
Instrument
Reagents and Consumables
Others
Global Pharmacogenomics Technology (Theranostics & CDx) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pharmacogenomics Technology (Theranostics & CDx) Market Segment Percentages, by Application, 2022 (%)
Tumor
Diabetes
Mental Diseases
Cardiovascular Diseases
Others
Global Pharmacogenomics Technology (Theranostics & CDx) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pharmacogenomics Technology (Theranostics & CDx) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmacogenomics Technology (Theranostics & CDx) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharmacogenomics Technology (Theranostics & CDx) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Roche
Agilent
Abbott
Thermofisher
Qiagen
Guardant Health
MGI Tech Co., Ltd.
Amoydx Biology
Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmacogenomics Technology (Theranostics & CDx), market overview.
Chapter 2: Global Pharmacogenomics Technology (Theranostics & CDx) market size in revenue.
Chapter 3: Detailed analysis of Pharmacogenomics Technology (Theranostics & CDx) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmacogenomics Technology (Theranostics & CDx) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.